Journal List > Tuberc Respir Dis > v.71(2) > 1001644

TOOLS
Yeo, Kang, Kang, Kim, Kim, Kim, Lee, and Moon: A Short-Term Effectiveness of Smoking Cessation Intervention in Outpatient Department of Pulmonology
Original Article
Tuberculosis and Respiratory Diseases

Tuberculosis and Respiratory Diseases 2011; 71(2): 114-119.

Published online: 31 August 2011

DOI: https://doi.org/10.4046/trd.2011.71.2.114

A Short-Term Effectiveness of Smoking Cessation Intervention in Outpatient Department of Pulmonology

Chang Dong Yeo, M.D., Hyeon Hui Kang, M.D., Ji Young Kang, M.D., Sung Kyoung Kim, M.D., Myung Sook Kim, M.D., Seung Soo Kim, M.D., Sang Haak Lee, M.D., Hwa Sik Moon, M.D.

Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.

Address for correspondence: Sang Haak Lee, M.D. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, St. Paul's Hospital, The Catholic University of Korea College of Medicine, 620-56, Jeonnong 1-dong, Dongdaemun-gu, Seoul 130-709, Korea. Phone: 82-2-961-4500, Fax: 82-2-968-7250, mdlee@catholic.ac.kr

Received 14 June 2011       Accepted 23 July 2011

Copyright © 2011. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Abstract

Background

There is very limited data present on smoking cessation rates in outpatient departments of pulmonology. In this study, we aimed to investigate the effectiveness of a brief smoking cessation intervention program in an outpatient department of pulmonology and identify predictors of smoking cessation failure.

Methods

After a brief recommendation of smoking cessation from pulmonologists, smokers willing to quit smoking were given individual counseling and supplement drugs. Fifty smokers were included in this study and baseline characteristics, smoking history and success rate were reviewed at 3 months.

Results

The mean age of the patients was 58.3±14.6 years and the total group of patients included 3 women. The rate of smoking cessation success was 74% at 3 months, and there were no differences in age, spirometric indexes and associated diseases between the smoking cessation success and failure group. The rate of supplement drug usage was not different in both groups either. However, body weight, mean number of cigarette usage per day and nicotine dependence scores in the failure group were significantly higher than in the success group. In multivariate analysis, body weight and mean number of cigarette usage per day were significant. Two smokers with a depressive disorder failed the smoking cessation.

Conclusion

A smoking cessation intervention program in the outpatient department of pulmonology showed a favorable success rate. More intensive interventions are needed to unfavorable groups which include the obese and heavy smokers.

Keywords: Smoking Cessation, Outpatients

Figures and Tables

Table 1
Baseline characteristics of the subjects
trd-71-114-i001

Values are expressed as mean±SD or number (%)

BMI: body mass index; FTND: fagerström test for nicotine dependence; FEV1: forced expiratory volume at one second; FVC: forced vital capacity; COPD: chronic obstructive pulmonary disease; SD: standard deviation.

Table 2
Comparison of clinical data with quitters and non-quitters
trd-71-114-i002

Values are expressed as mean±SD or number (percent).

BMI: body mass index; FTND: Fagerström test for nicotine dependence; FEV1: forced expiratory volume at 1 second; FVC: forced vital capacity; COPD: chronic obstructive pulmonary disease; SD: standard deviation.

Table 3
Multivariate logistic regression analysis of factors predicting smoking cessation success
trd-71-114-i003

FTND: Fagerström test for nicotine dependence; OR: odds ratio; CI: confidence interval.

Acknowledgements

We authors thank Sun Hee Gang, a nurse in outpatient department of pulmonology, for data collection and management.

References

1. Volpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med. 2009. 360:699–709.
2. Fiore MC, McCarthy DE, Jackson TC, Zehner ME, Jorenby DE, Mielke M, et al. Integrating smoking cessation treatment into primary care: an effectiveness study. Prev Med. 2004. 38:412–420.
3. Kim YH, Lee SH. Smoking cessation. Tuberc Respir Dis. 2010. 69:153–162.
4. Kim MH. Updates in smoking cessation programs. Korean J Health Psychol. 2005. 10:259–276.
5. Goodfellow LT, Waugh JB. Tobacco treatment and prevention: what works and why. Respir Care. 2009. 54:1082–1090.
6. Cheong YS, Ahn SH. Effect of multi-modal interventions for smoking cessation in a university setting: a short course of varenicline, financial incentives, e-mail and short message service. Korean J Fam Med. 2010. 31:355–360.
7. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010. 340:b5569.
8. Andreas S, Hering T, Mühlig S, Nowak D, Raupach T, Worth H. Smoking cessation in chronic obstructive pulmonary disease: an effective medical intervention. Dtsch Arztebl Int. 2009. 106:276–282.
9. Seo NS, Kim YH, Kang HY. The effects of a group smoking cessation program among adult smokers in a rural community. J Korean Acad Nurs. 2007. 37:1139–1148.
10. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006. 296:47–55.
11. Pohlig C. Smoking cessation counseling: a practice management perspective. Chest. 2006. 130:1231–1233.
12. Bars MP, Banauch GI, Appel D, Andreachi M, Mouren P, Kelly KJ, et al. "Tobacco free with FDNY": the New York City Fire Department World Trade Center tobacco cessation study. Chest. 2006. 129:979–987.
13. Hotta K, Kinumi K, Naito K, Kuroki K, Sakane H, Imai A, et al. An intensive group therapy programme for smoking cessation using nicotine patch and internet mailing supports in a university setting. Int J Clin Pract. 2007. 61:1997–2001.
14. Rennard SI, Daughton DM. Smoking cessation. Chest. 2000. 117:5 Suppl 2. 360S–364S.
15. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA. 1994. 271:589–594.
16. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict. 1991. 86:1119–1127.
17. Lerman C, Kaufmann V, Rukstalis M, Patterson F, Perkins K, Audrain-McGovern J, et al. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial. Ann Intern Med. 2004. 140:426–433.
18. Glassman AH, Stetner F, Walsh BT, Raizman PS, Fleiss JL, Cooper TB, et al. Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA. 1988. 259:2863–2866.
19. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. Depression and the dynamics of smoking. A national perspective. JAMA. 1990. 264:1541–1545.
20. Niaura R, Britt DM, Shadel WG, Goldstein M, Abrams D, Brown R. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav. 2001. 15:13–17.
21. Kim TS, Kim DJ. The association between smoking and depression. Korean J Psychopharmacol. 2007. 18:393–398.
TOOLS
Similar articles